Authors
Arnulf H Hölscher, Martin Hemmerich, Stefanie Albert, Javed Parvez, Christin Lenk, Stephan Johannsen, Peter M Markus
Published in
Zentralblatt fur Chirurgie. Oct 09, 2026. Epub Oct 09, 2026.
Abstract
Real world data of unselected series with standardised management are important for the comparison of different techniques of minimally invasive oesophagectomy.
This is a retrospective study of a consecutive cohort of 193 minimally invasive hybrid oesophagectomies (laparoscopic/thoracotomy) including 9 conversions (4.6%) and 4 primary open oesophagectomies, in total with 195 gastric and 2 colonic interpositions (196 intrathoracic anastomoses and 1 cervical esophagogastrostomy). No patient had distant metastasis except 1 with hepatic lesions, who was resected, because of recurrent cancer bleeding during chemotherapy. 78% had adeno- and 20% squamous cell carcinomas. 65 of the tumours were cT3, 20 % cT2, 14% cT1. 77% of the patients underwent neoadjuvant chemotherapy with FLOT or radiochemotherapy with CROSS including 6 with definitive radiochemotherapy and salvage surgery.
The R0-resection rate was 99% and a median of 34 lymph nodes was resected. The rate of anastomotic leakage was 1.5%, (n = 3), pneumonia 11%, chylothorax 1.5%, postoperative bleeding 0,5% and revisional surgery 2%. The 30- and 90- day mortality rates were 1.5% or 4.6%, respectively. One of 3 patients with anastomotic leakage had a fatal outcome despite endoscopic therapy.
The reported technique of hybrid minimally invasive oesophagectomy is safe, with a very low rate of anastomotic leakage. This benchmark is important for the comparison with the results of other types of minimally invasive Ivor-Lewis oesophagectomy.
PMID:
42855143
Bibliographic data and abstract were imported from PubMed on 10 Oct 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 5
- Comments 0